Armistice Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-108,000
| Closed | -$7.5M | – | 245 |
|
|
2025
Q1 | $7.5M | Sell |
108,000
-604,000
| -85% | -$41.9M | 0.11% | 95 |
|
|
2024
Q4 | $61.2M | Buy |
712,000
+147,000
| +26% | +$12.6M | 0.84% | 22 |
|
|
2024
Q3 | $67.3M | Buy |
565,000
+21,000
| +4% | +$2.5M | 1.08% | 13 |
|
|
2024
Q2 | $77.7M | Buy |
544,000
+144,000
| +36% | +$20.6M | 0.98% | 9 |
|
|
2024
Q1 | $51.4M | Buy |
400,000
+4,000
| +1% | +$514K | 0.68% | 17 |
|
|
2023
Q4 | $41M | Sell |
396,000
-40,000
| -9% | -$4.14M | 0.56% | 29 |
|
|
2023
Q3 | $39.6M | Sell |
436,000
-104,000
| -19% | -$9.46M | 0.61% | 31 |
|
|
2023
Q2 | $43.7M | Sell |
540,000
-44,000
| -8% | -$3.56M | 0.63% | 30 |
|
|
2023
Q1 | $46.5M | Sell |
584,000
-40,000
| -6% | -$3.18M | 0.67% | 30 |
|
|
2022
Q4 | $42.2M | Buy |
+624,000
| New | +$42.2M | 0.74% | 30 |
|